-
摘要: 目的:了解肾肿瘤行肾部分切除术后肾功能的变化情况。方法:2010年1月~2013年5月施行肾部分切除术61例,采集患者年龄、性别、体质指数(body mass index,BMI)、伴随疾病(高血压、糖尿病、冠心病)、肿瘤的病理类型、采用简化MDRD公式计算出的eGFR、右肾小球滤过率(rGFR)及术后3~6个月的eGFR,分析术前及术后肾功能变化情况及相关因素。结果:术前肾功能Ⅰ级68%,Ⅱ级25%,Ⅲ级7%。21%患者术后肾功能恶化至中度肾功能损伤(Ⅲ级及以上),与患者年龄(OR=0.985,P=0.039)、术前肾功能水平即eGFR(OR=1.328,P=0.002)、肾动脉阻断时间(OR=0.913,P=0.037)、肿瘤直径(OR=0.996,P=0.011)相关。结论:患者增加的年龄、术前肾功能水平、肾动脉阻断时间以及肿瘤直径是术后出现肾功能恶化至中度肾功能损伤(Ⅲ级及以上)的独立危险因素。Abstract: Objective:To evaluate the renal function before and after partial nephrectomy.Method:We retrospectively reviewed the records of 61 patients treated with partial nephrectomy for renal tumor including patients' age, sex, BMI, concomitant diseases and pathologic characteristics. The abbreviated Modification of Diet in Renal Disease (MDRD) equation was used to calculate estimate glomerular filtration rate (eGFR). Multivariate logistic regression models tested the association of newly acquired chronic kidney disease stage Ⅲ or greater with pertinent demographic, tumor and surgical factors.Result:At baseline 68%, 25% and 7% of patients had chronic kidney disease stage Ⅰ, Ⅱ and Ⅲ, respectively. Over the follow-up period of 3-6 months 21% of patients progressed to chronic kidney disease stage Ⅲ or greater. Increasing age(OR=0.985, P=0.039), lower preoperative eGFR (OR=1.328, P=0.002), clamping time of renal artery (OR=0.913, P=0.037), increasing tumor size (OR=0.996, P=0.011) were independently associated with newly acquired chronic kidney disease stage III or greater.Conclusion:Chronic kidney disease stage Ⅲ or greater will develop postoperatively in 21% of patients, and this progression is associated with increasing age, preoperative renal function, clamping time of renal artery and tumor diameter.
-
Key words:
- kidney neoplasms /
- partial nephrectomy /
- kidney function
-
-
[1] Jemal A, Bray F, Center M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[2] Chow W H, Devesa S S, Warren J L, et al. Rising incidence of renal cell cancer in the United States[J]. JAMA, 1999, 281(17): 1628-1631.
[3] Peycelon M, Hupertan V, Comperat E, et al. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm[J]. J Urol, 2009, 181(1): 35-41.
[4] Becker F, Siemer S, Humke U, et al. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients[J]. Eur Urol, 2006, 49(2): 308-313.
[5] Huang W C, Donin N M. Partial nephrectomy is the standard of care for T1a kidney tumors[J]. Urol Oncol, 2013, 31(2): 140-143.
[6] Kim S P, Murad M H, Thompson R H, et al. Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis[J]. J Urol, 2012, pii: S0022-5347(12)05254-8.
[7] Rule A D, Larson T S, Bergstralh E J, et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease[J]. Ann Intern Med, 2004, 141(12): 929-937.
[8] Kopple J D. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure[J]. Am J Kidney Dis, 2001, 37(1 Suppl 2): S66-S70.
[9] Stevens L A, Levey A S. Measurement of kidney function[J]. Med Clin North Am, 2005, 89(3): 457-473.
[10] Levey A S, Stevens L A, Schmid C H, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612.
[11] Nguyen M M, Gill I S, Ellison L M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program[J]. J Urol, 2006, 176(6 Pt 1): 2397-2400, 2400.
[12] Crispen P L, Viterbo R, Boorjian S A, et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance[J]. Cancer, 2009, 115(13): 2844-2852.
[13] Shikanov S, Clark M A, Raman J D, et al. Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy[J]. J Urol, 2010, 184(5): 1867-1871.
[14] Iida S, Kondo T, Amano H, et al. Minimal effect of cold ischemia time on progression to late-stage chronic kidney disease observed long term after partial nephrectomy[J]. Urology, 2008, 72(5): 1083-1088, 1088-1089.
[15] Clark M A, Shikanov S, Raman J D, et al. Chronic kidney disease before and after partial nephrectomy[J]. J Urol, 2011, 185(1): 43-48.
[16] Kumar R. Partial nephrectomy for small renal tumors may prevent chronic kidney disease[J]. Indian J Urol, 2008, 24(2): 275-276.
[17] Russo P. Partial nephrectomy achieves local tumor control and prevents chronic kidney disease[J]. Expert Rev Anticancer Ther, 2006, 6(12): 1745-1751.
[18] Porpiglia F, Renard J, Billia M, et al. Is renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible? One-year results of a prospective study[J]. Eur Urol, 2007, 52(4): 1170-1178.
[19] Textor S C, Lerman L. Renovascular hypertension and ischemic nephropathy[J]. Am J Hypertens, 2010, 23(11): 1159-1169.
-
计量
- 文章访问数: 266
- PDF下载数: 305
- 施引文献: 0